Phenazopyridine‐Induced Sulfhemoglobinemia
Clinical Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/ccr3.73912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 09.11.2026. Verfasst von Waldemar Irizarry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Northeast Ohio Medical University Rootstown Ohio USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prolonged phenazopyridine exposure can cause sulfhemoglobinemia and suspected oxidative hemolytic anemia. Persistent low pulse oximetry readings with indeterminate co‐oximetry warrant laboratory consultation. Management requires withdrawal of the offending drug and supportive care; methylene blue does not reverse sulfhemoglobinemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Northeast Ohio Medical University Rootstown Ohio USA.
- Department of Internal Medicine Akron General Medical Center Akron Ohio USA.
- Department of Science and Engineering Barrington High School Barrington Illinois USA.
ORCID-Profile: Waldemar Irizarry, Astha Guliani
Zitieren
APA
Irizarry, W., Taylor, A., Arora, A., & Guliani, A. (2026). Phenazopyridine‐Induced Sulfhemoglobinemia. Clinical Case Reports, 14(11). https://doi.org/10.1002/ccr3.73912
Vancouver
Irizarry W, Taylor A, Arora A, Guliani A. Phenazopyridine‐Induced Sulfhemoglobinemia. Clinical Case Reports. 2026;14(11). doi:10.1002/ccr3.73912
BibTeX
@article{Irizarry2026,
author = {Irizarry, Waldemar and Taylor, Ashton and Arora, Amaya and Guliani, Astha},
title = {Phenazopyridine‐Induced Sulfhemoglobinemia},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/ccr3.73912}
}
EUVIMED